Ira Duarte
Principal Accounting Officer, CORNERSTONE THERAPEUTICS INC.
Companies
- HERON THERAPEUTICS, INC. /DE/Chief financial officer Jun 23, 2023 to now1
- TerrAscend Corp.Board member Dec 9, 2022 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- TerrAscend Corp. TSNDF657,930 shares3$315.8K at $0.48Jun 24, 2025
- HERON THERAPEUTICS, INC. /DE/ HRTX281,899 shares4$98.7K at $0.35Jul 31, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 31, 2026Shares withheld for tax 3,326 shares at $0.50 of HERON THERAPEUTICS, INC. /DE/4
- Jul 31, 2026Exercised options 11,694 shares of HERON THERAPEUTICS, INC. /DE/4
- Jul 30, 2026Shares withheld for tax 3,850 shares at $0.50 of HERON THERAPEUTICS, INC. /DE/4
- Jul 30, 2026Exercised options 13,535 shares of HERON THERAPEUTICS, INC. /DE/4
- Jul 19, 2026Shares withheld for tax 1,101 shares at $0.47 of HERON THERAPEUTICS, INC. /DE/5
- Jul 19, 2026Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/5
- Jun 16, 2026Shares withheld for tax 3,555 shares at $0.38 of HERON THERAPEUTICS, INC. /DE/6
- Jun 16, 2026Exercised options 12,500 shares of HERON THERAPEUTICS, INC. /DE/6
- Apr 30, 2026Exercised options 13,535 shares of HERON THERAPEUTICS, INC. /DE/7
- Apr 30, 2026Exercised options 11,694 shares of HERON THERAPEUTICS, INC. /DE/7
- Apr 19, 2026Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/8
- Jan 31, 2026Exercised options 11,695 shares of HERON THERAPEUTICS, INC. /DE/9
- Jan 19, 2026Exercised options 3,875 shares of HERON THERAPEUTICS, INC. /DE/10
- Oct 31, 2025Exercised options 11,694 shares of HERON THERAPEUTICS, INC. /DE/11
- Oct 19, 2025Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/12
- Jul 31, 2025Exercised options 11,695 shares of HERON THERAPEUTICS, INC. /DE/13
- Jul 19, 2025Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/14
- Jun 24, 2025Granted 433,653 shares of TerrAscend Corp.3
- Jun 16, 2025Exercised options 12,500 shares of HERON THERAPEUTICS, INC. /DE/15
- Apr 30, 2025Exercised options 11,694 shares of HERON THERAPEUTICS, INC. /DE/16
- Apr 19, 2025Exercised options 3,875 shares of HERON THERAPEUTICS, INC. /DE/17
- Jan 19, 2025Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/18
- Dec 31, 2024Shares withheld for tax 71,704 shares at $0.65 of TerrAscend Corp.19
- Oct 19, 2024Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/20
- Jul 19, 2024Exercised options 3,875 shares of HERON THERAPEUTICS, INC. /DE/21
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARTerrAscend Corp., Board member
- 3
- 4
- 5SEC EDGARForm 4 filed Jul 20, 2026
- 6SEC EDGARForm 4 filed Jun 17, 2026
- 7SEC EDGARForm 4 filed May 4, 2026
- 8SEC EDGARForm 4 filed Apr 21, 2026
- 9SEC EDGARForm 4 filed Feb 3, 2026
- 10SEC EDGARForm 4 filed Jan 20, 2026
- 11SEC EDGARForm 4 filed Nov 4, 2025
- 12SEC EDGARForm 4 filed Oct 21, 2025
- 13SEC EDGARForm 4 filed Aug 4, 2025
- 14SEC EDGARForm 4 filed Jul 22, 2025
- 15SEC EDGARForm 4 filed Jun 17, 2025
- 16SEC EDGARForm 4 filed May 2, 2025
- 17SEC EDGARForm 4 filed Apr 22, 2025
- 18SEC EDGARForm 4 filed Jan 22, 2025
- 19SEC EDGARForm 4 filed Jan 3, 2025
- 20SEC EDGARForm 4 filed Oct 21, 2024
- 21SEC EDGARForm 4 filed Jul 22, 2024